11 May 2015 : Original article
Efficacy and Safety of Low Accelerating Dose Regimen of Interferon/Ribavirin Antiviral Therapy in Patients with Hepatitis C Virus Recurrence after Liver Transplantation
DOI: 10.12659/AOT.892255
Ann Transplant 2015; 20:263-268
HTML version available soon